A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe

A disease state approach to the pharmacological management of Type 2 diabetes in primary care : A position statement by Primary Care Diabetes Europe

Seidu, S. (author): Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, United Kingdom

Cos, X. (author): Sant Marti de Provençals Primary Care Centres, Institut Català de la Salut, University Research Institute in Primary Care (IDIAP Jordi Gol), Barcelona, Spain

Harris, S. B. (author): Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

Jansson, Stefan P. O., 1959- (author): Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län

Mata-Cases, M. (author): La Mina Primary Care Centre, Institut Català de la Salut, University Research Institute in Primary Care (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain

Neijens, A. M. J. (author): Praktijk De Diabetist, Nurse-Led Case Management in Diabetes, QOL-consultancy, Deventer, The Netherland

Topsever, P. (author): Department of Family Medicine, Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey

Khunti, K. (author): Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, United Kingdom

(creator_code:org_t)

Elsevier, 2021
2021
English.
In: Primary Care Diabetes. - : Elsevier. - 1751-9918 .- 1878-0210. ; 15:1, s. 31-51

Related links:: http://www.primary-c...; show more...; https://urn.kb.se/re...; https://doi.org/10.1...; show less...

Abstract Subject headings

Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimising glycaemic control is increasing, especially on the frontlines of patient care. In many countries, most patients with type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the challenge of the growing plethora of available treatment options for managing hyperglycaemia, leading to difficultly in making treatment decisions and contributing to therapeutic inertia. This position statement offers a simple and patient-centred clinical decision-making model with practical treatment recommendations that can be widely implemented by primary care clinicians worldwide through shared-decision conversations with their patients. It highlights the importance of managing cardiovascular disease and elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and treatment strategies that connect patients with the most effective care.

MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

By the author/editor: Seidu, S.; Cos, X.; Brunton, S.; Harris, S. B.; Jansson, Stefan ...; Mata-Cases, M.; show more...; Neijens, A. M. J ...; Topsever, P.; Khunti, K.; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Endocrinology an ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.